Javier Calvo

ORCID: 0000-0001-9564-0016
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Systemic Lupus Erythematosus Research
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Sclerosis and Related Diseases
  • Spondyloarthritis Studies and Treatments
  • Psoriasis: Treatment and Pathogenesis
  • Blood properties and coagulation
  • Venous Thromboembolism Diagnosis and Management
  • Erythrocyte Function and Pathophysiology
  • Eosinophilic Disorders and Syndromes
  • Thyroid Cancer Diagnosis and Treatment
  • Diabetes Management and Research
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Ocular Diseases and Behçet’s Syndrome
  • Bone and Joint Diseases
  • Lymphatic System and Diseases
  • Thermal Regulation in Medicine
  • Congenital Anomalies and Fetal Surgery
  • Autoimmune and Inflammatory Disorders Research
  • Blood Coagulation and Thrombosis Mechanisms
  • Bone health and treatments
  • Atrial Fibrillation Management and Outcomes
  • Lipoproteins and Cardiovascular Health
  • Therapeutic Uses of Natural Elements
  • Salivary Gland Disorders and Functions
  • Nerve Injury and Rehabilitation

Hospital General Universitario De Valencia
2008-2021

Hospital Universitario Miguel Servet
2019

Universidad de Cantabria
2017

Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública
2017

Ministerio de Agricultura y Ganadería de Costa Rica
2016

Hospital Universitario Reina Sofía
2015

Instituto Maimónides de Investigación Biomédica de Córdoba
2015

Hospital Universitario Fundación Jiménez Díaz
2015

Hospital Universitario La Paz
2013

Hospital Universitari i Politècnic La Fe
2004

Objectives To analyze whether oxidative stress ( OS ) changes are present in patients with bisphosphonate‐related osteonecrosis of the jaw BRONJ versus controls. Materials and Methods Oxidative was analyzed serum unstimulated saliva three groups: Group 1 consisted 24 who had been treated intravenous bisphosphonates (iv BP s) developed , group 2 20 received iv s did not develop 3 comprised 17 control subjects. Reduced glutathione GSH ), malondialdehyde MDA oxidized GSSG...

10.1111/jop.12151 article EN Journal of Oral Pathology and Medicine 2014-01-23
Carmen García‐Gómez María A. Martín‐Martínez Santos Castañeda Fernando Sánchez‐Alonso Miren Uriarte-Ecenarro and 95 more Carlos González‐Juanatey Montserrat Romera Baurés José Santos-Rey José Antonio Pinto-Tasende Estefanía Quesada‐Masachs Jesús Tornero-Molina Olga Martínez González Tatiana Cobo‐Ibáñez Eugenio Chamizo-Carmona Sara Manrique‐Arija Dolores Fábregas-Canales Federico Díaz‐González Javier Llorca Miguel Á. González‐Gay Eugenia Gonzalez de Rábago Elena Alonso Blanco Morales J. Carlos Fernández López Natividad Oreiro Villar Antonio Atanes Sandoval Francisco J. Blanco Cayetano Alegre de Miquel Maria J Fernandez Ramón Huguet Codina Beatriz Yoldi Mercedes Ramentol G. Ávila Sara Marsal Barril Martina Steiner Santiago León Atehortúa Muñoz Fernando Gamero José García Torón María Pilar Gil Antonio Juan Más Pilar Espiño Inmaculada Ros Mónica Ibáñez Claudia Murillo José A. Piqueras Raimón Sanmartí Horacio Berman Sonia Cabrera Virginia Ruiz‐Esquide Oscar Fontseré Patón Benjamín Gutiérrez Lydia Abásolo María D. Fábregas Joan M. Nolla Miriam García Arias Alberto García-Vadillo Rosario García‐Vicuña Antonio Fernández‐Nebro María Angeles Belmonte López Inmaculada Ureña‐Garnica María Victoria Irigoyen V. Coret Cagigal Ruth López González Daniel Pielfort Garrido Juana Sampedro Álvarez Ángel María García Aparicio Rebeca Belmonte Gómez Pastora Granados Bautista Azucena Hernández Sanz Carmen Olga Sánchez González Javier Bachiller‐Corral Antonio Zea Francisco Javier Gutiérrez‐Mañero F. Jiménez Zorzo Eugenio Giménez Úbeda J. M. Álvaro Gracia Chesús Beltrán Audera Marta Medrano Ángela Pecondón Celia Erausquin Soledad Ojeda Juan Carlos Quevedo Félix Francisco Carlos Rodríguez Lozano Jesús Babío Herráez Francisco Javier López Longo D. Gerona Carlos González Luis Carreño I. Monteagudo Javier del Pino María Dolores Sánchez González Alfonso Corrales María Enriqueta Peiró José Gallego J. Rosas Isabel Rotés E. Moreno Alba Erra Dolors Grado Javier Calvo Amalia Rueda

10.1016/j.jacl.2017.02.018 article EN Journal of clinical lipidology 2017-03-16

We sought to determine the most appropriate method for measuring salivary flow aid diagnosis of Sjögren's syndrome (SS). Specifically, we compared unstimulated whole rate (UWSFR) with stimulated (SWSFR).This case-control study comprised one group 103 patients SS and a control 50 healthy people. measured UWSFR SWSFR in both groups according guidelines established by Navacet [1993].The were significantly lower patient controls (p < 0.01). Among participants group, found decreased 84...

10.4317/medoral.24736 article EN Medicina oral, patología oral y cirugía bucal 2021-01-01

Background . Activating mutations in the RET gene leads to medullary thyroid carcinoma (MTC). Guidelines encourage performing analysis subjects with hereditary and sporadic disease. Materials Methods Design Observational, case series report study. Patients Subjects diagnosed MTC, a thyroidectomy performed single center Costa Rica between years 2006 2015. Diagnosis Follow-Up Pre- postoperative calcitonin, mutation, neck ultrasound tomography were obtained. Results 21 histological diagnosis of...

10.1155/2016/9637173 article EN cc-by Journal of Cancer Epidemiology 2016-01-01

Systemic lupus erythematosus (SLE) is characterised by increased venous and arterial thrombotic risk. Although antiphospholipid antibodies (APAs) have been shown to be related with tendency in these patients, more than 40% of them, thrombosis occurs without the presence such antibodies. We analysed association events acquired (anticardiolipin (ACAs) anticoagulant (LA)) inherited (antithrombin (AT), protein C (PC), S (PS) deficiencies, factor V Leiden prothrombin G20210A mutation),...

10.3233/ch-2008-1117 article EN Clinical Hemorheology and Microcirculation 2008-01-01

Psoriasis is a systemic inflammatory disorder with increased cardiovascular risk which has been partly attributed to the prevalence of metabolic syndrome (MS). However, contribution rheological alterations scarcely investigated. In 91 psoriasis patients and in 101 healthy volunteers, we determined profile (fibrinogen, blood viscosity erythrocyte aggregation), along lipidic parameters. Patients showed statistically higher BMI, waist, triglycerides, insulin, c-reactive protein (CRP),...

10.3233/ch-2012-1639 article EN Clinical Hemorheology and Microcirculation 2013-01-01

Systemic lupus erythematosus (SLE) is characterised by increased venous and arterial thrombotic risk. Nevertheless, how hemorheological alterations contribute to risk remains a question of debate. We aimed determine the rheological profile in 105 patients with SLE (24 event) healthy controls. determined blood viscosity erythrocyte aggregation along plasma lipids fibrinogen. Although showed lower at 230 s(-1) native hematocrit when compared controls (p < 0.001), differences disappeared after...

10.3233/ch-2011-1508 article EN Clinical Hemorheology and Microcirculation 2012-01-01

Raynaud's phenomenon (RP) is an episodic peripheral circulatory disorder characterized by local artery spams in subjects exposed to cold or emotional stress. It not well-established whether RP patients show altered rheological profile, mostly due patient classification and clinical severity. We aimed compare the hemorheological profile with primary secondary a healthy control group. Eighteen RP, 22 controls, were included study. also divided according presence of digital ulcers (7 with, 33...

10.3233/ch-131723 article EN Clinical Hemorheology and Microcirculation 2014-01-01

The relationship between rheological alterations and systemic sclerosis (SSc) is not well established. We have determined in 27 patients with SSc (4 male, 21 female ) aged 59 +/- 14 years a matched control group the whole profile, i.e. blood viscosity (BV), plasma (PV), erythrocyte aggregation (EA), deformability (ED) along fibrinogen (Fbg), C-reactive protein (CRP), lipids, indices. Patients show higher Fbg, PV EA (P<0.01) lower ED (P<0.01). A negative significant correlation was found...

10.3233/ch-2008-1133 article EN Clinical Hemorheology and Microcirculation 2008-01-01

The association between hyperhomocysteinemia (HHcy) and Raynaud's phenomenon (RP) remains a matter of debate. In 18 primary RP, 23 secondary RP 41 controls, we investigated homocysteine (Hcy) levels along with biochemical inflammatory parameters. Hcy in both were elevated when compared controls (p < 0.05 p 0.01, respectively). As age was higher as 0.01), age-matched corresponding control group, maintaining its statistical significance 0.05). No differences creatinine, B12 vitamin or folic...

10.3233/ch-131681 article EN Clinical Hemorheology and Microcirculation 2014-01-01

<h3>Background</h3> Biological therapies have greatly improved the management of psoriatic arthritis (PsA). Minimal disease activity (MDA) has become optimal target in treatment PsA, waiting for a standardized definition remission. Knowing proportion PsA patients MDA state could inform on quality these patients. <h3>Objectives</h3> To determine prevalence (Coates et al.) with Spain as well its potential predictors. evaluate association between and impact disease, evaluated by Impact Disease...

10.1136/annrheumdis-2016-eular.3250 article EN Annals of the Rheumatic Diseases 2016-06-01

10.1016/j.rceng.2016.11.001 article EN Revista Clínica Española (English Edition) 2016-12-09

<h3>Background</h3> Macrophages play a key role in the pathogenesis of rheumatoid arthritis (RA). Under certain stimulus conditions these cells are able to switch their phenotypes M1 or M2 states, which characterized by different inflammatory and tissue repair properties. Thus, macrophages predominantly recruited states associated with tisular damage. An imbalance M1/M2 proportion has been reported synovium RA patients. The molecular mechanisms undertaken this phenotypic switching not...

10.1136/annrheumdis-2015-eular.3032 article EN Annals of the Rheumatic Diseases 2015-06-01

Kollmann, Camaiora A.; Del Blanco, B.; Alsina, E.; Brogly, N.; Calvo, J. M.; Gilsanz, F. Author Information

10.1097/00003643-201306001-00708 article EN European Journal of Anaesthesiology 2013-06-01

Introduction: Heat stroke is a situation conditioned by the inability of body to dissipate excess heat produced physical exercise. The association liver damage not rare, but some patients may progress fulminant hepatic failure (FHF) requiring transplantation. So far, only 5 exertional cases transplantation have been reported in literature. Patients and methods: We performed retrospective review all undergone our department we found 2 which etiology was stroke. Results: first case man 23...

10.1097/00007890-201211271-01315 article EN Transplantation 2012-11-01

<h3>Objectives</h3> To identify the factors that are related with response to Apremilast(APR) in Psoriatic Arthritis(PsA). <h3>Methods</h3> An observational and analytical multicenter retrospective study. There included PsA patients treated APR after two years of commercialization. Clinical demographic data were collected: disease duration, previous treatments, cutaneous joint involvement pattern defined as: exclusively, non mixed (by several domains combination). It was duration treatment,...

10.1136/annrheumdis-2019-eular.8099 article EN Annals of the Rheumatic Diseases 2019-06-01

Background: Heparin is a widely used drug. The most frequent complication derived from its use the haemorrhage. However, an uncommon but potentially serious adverse effect heparin‐induced thrombocytopenia (HIT). goal of treatment HIT to reduce platelet activation and thrombin formation decrease risk thrombosis. Argatroban drug choice in patients as alternative anticoagulant critically ill with high haemorrhage, postoperative cardiac events or renal failure, since it allows close control...

10.1097/01.hs9.0000567504.77628.6c article EN cc-by-nc-nd HemaSphere 2019-06-01

Background: Objectives: Analyse the effect of secukinumab in terms patient´s own variables, specifically: fatigue, sleep, pain and quality life patients with psoriatic arthritis or spondyloarthritis. Methods: A multicentric longtitudinal observational prospective study was carried out at 6 months who begin treatment secukinumab. At start after following data collected on outcome: through an visual analogue scale (VAS), fatigue using FACIT-fatigue scale, sleeping problems insomnia severity...

10.1136/annrheumdis-2020-eular.2795 article EN Annals of the Rheumatic Diseases 2020-06-01
Coming Soon ...